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Weill-Marchesani syndrome (WMS) is characterized by the association of short stature; brachydactyly; joint stiffness;
eye anomalies, including microspherophakia and ectopia of the lenses; and, occasionally, heart defects. We have
recently mapped a gene for the autosomal recessive form of WMS to chromosome 19p13.3-p13.2, in a 12.4-cM
interval. Here, we report null mutations in a member of the extracellular matrix protease family, the gene encoding
ADAMTS10, a disintegrin and metalloprotease with thrombospondin motifs. A total of three distinct mutations
were identiﬁed in two consanguineous families and in one sporadic WMS case, including one nonsense mutation
(R237X) and two splice mutations (1190+1GrA and 810+1GrA). ADAMTS10 expression studies using reverse-
transcriptase polymerase chain reaction, northern blot, and dot-blot analyses showed that ADAMTS10 is expressed
in skin, fetal chondrocytes, and fetal and adult heart. Moreover, electron microscopy and immunological studies
of the skin ﬁbroblasts from the patients conﬁrmed impairment of the extracellular matrix. We conclude, therefore,
that ADAMTS10 plays a major role in growth and in skin, lens, and heart development in humans.
Introduction
Weill-Marchesani syndrome (WMS [MIM 277600]) is
characterized by the association of short stature; brachy-
dactyly; joint stiffness; eye anomalies, including micro-
spherophakia, ectopia of the lenses, severe myopia, and
glaucoma; and, occasionally, heart defects. Despite the
disease’s clinical homogeneity, autosomal recessive (AR)
and autosomal dominant (AD) modes of inheritance
have been reported, and we have recently identiﬁed an
in-frame deletion of the ﬁbrillin 1 gene in a family with
AD WMS (Faivre et al. 2003a, 2003b). Using a homo-
zygosity-mapping strategy in two consanguineous fam-
ilies from Lebanon and Saudi Arabia, we reported link-
age of the AR WMS gene to chromosome 19p13.3-
p13.2, in a 12.4-cM interval (Faivre et al. 2002). Several
candidate genes involved in the extracellular matrix
(ECM) structure were considered, including the gene
encoding ADAMTS10 (GenBank accession numberNM_
030957), a disintegrin and metalloprotease with throm-
bospondin (TS) motifs. Here, we present three distinct
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mutations of the ADAMTS10 gene in these two families
and in one sporadic WMS case, including one nonsense
mutation and two splice mutations. Previous electron
microscopy studies of skin ﬁbroblasts from affected in-
dividuals suggested an impairment of the ECM, and our
immunological data support the disorganization of the
cytoskeleton in WMS. The data presented here provide
the ﬁrst evidence of the involvement of a member
of the ADAMTS family in brachydactyly and micro-
spherophakia.
Material and Methods
Patients
A total of six children belonging to three families were
included in the present study. In two sibships, an AR
mode of inheritance has been established, and the disease
gene has been mapped to chromosome 19p13.3 (Faivre
et al. 2002). The disease in the third subject is isolated
and sporadic. All affected children fulﬁlled the criteria
for WMS—that is, short stature, brachydactyly, limita-
tion of joint movement, microspherophakia, dislocated
lenses, severe myopia, and glaucoma. Additional fea-
tures included pulmonary stenosis (in two patients) and
aortic and pulmonary stenosis with dysplastic valves
and hypertrophic obstructive cardiomyopathy (in two
patients).
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Figure 1 Structure of the ADAMTS10 gene. The three mutations are located in the metalloprotease domain.
Molecular Studies
Blood samples were obtained with the written consent
of the patients and unaffected relatives. Genomic DNA
was extracted from leukocytes, according to standard
procedures. A series of 48 intronic primers (available on
request) were designed to amplify the 24 coding exons
of the ADAMTS10 gene. Ampliﬁcation products were
puriﬁed and sequenced by use of the ﬂuorescent dideoxy-
terminator method on an ABI 3100 automatic sequencer.
Total RNAs were extracted from human primary cul-
tured cells (fetal chondrocytes and skin ﬁbroblasts)
through use of the RNeasy Mini Kit (Qiagen). cDNAwas
synthesized by primingwith randomhexamers in thepres-
ence of MuLV reverse transcriptase through use of the
manufacturer’s protocol (GeneAmp RNA PCR Core Kit
[Roche]). Thirty-ﬁve to 40 PCR cycles were performed,
at an annealing temperature of 56C, to amplify a 470-
bp fragment speciﬁc for the ADAMTS10 gene (forward:
5′-TGCAGCGTCAATGAGGACAT-3′; reverse: 5′-AGC-
ACCACCCCTTGTCGAT-3′). Sequences of the sense and
antisense primers used for glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) ampliﬁcation were as follows:
5′-AGACAGCCGCATCTTCTTGT and 3′-CCACAGT-
CTTCTGAGTGGCA (587 bp).
Premade northern blot containing 2 mg of poly(A)
RNA per lane from four human fetal tissues (brain,
lung, liver, and kidney) and a human multiple-tissue
expression array were used (ref 7756-1 and ref 7776-
1 [Clontech Laboratories]). A 413-bp cDNA fragment
of ADAMTS10 was obtained by ampliﬁcation of ﬁbro-
blast cDNA. The sense and antisense primer sequences
were 5′-CCTAGCGGAAGGCTTCAACT and 3′-AGTC-
GCAGTTGAAAGGTGGT, respectively. This fragment
was then puriﬁed, labeled by random priming (Amer-
sham Pharmacia Biotech), and incubated overnight in a
hybridization buffer at 42C. The two blots werewashed
three times at 42C with 2#SSC:0.1% SDS for 15 min
and once under more stringent conditions, at 65C with
0.1#SSC:0.1% SDS for 20 min. The blots were then
exposed to Kodak X-Omat ﬁlms with an intensifying
screen at 80C.
Immunological Studies
Subconﬂuent control and WMS ﬁbroblasts grown on
a plastic support were ﬁxed with 4% paraformaldehyde
in PBS for 30 min. Cells were then stained with Phal-
loidin-Alexa (Molecular Probes) and examined by con-
focal microscopy.
Results
More than 100 known genes were found to map to the
WMS critical region on chromosome 19p13 through use
of publicly available sequences (National Center for
Biotechnology Information; the Human Genome Work-
ing Draft at the University of California–Santa Cruz Ge-
nome Bioinformatics Web site). Of these genes, ﬁve were
regarded as possible candidate genes on the basis of their
function—namely,COL5A3; intercellular adhesionmol-
ecule 1, 4, and 5 (ICAM1, -4, and -5); the SWI/SNF-
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Table 1
ADAMTS10 Mutations Identiﬁed in Three Families with WMS
Family
Country
of Origin
Parents
Consanguineous Nucleotide Change Amino Acid Change
Mutated
Exon(s)
1 Lebanon Yes 709CrT/709CrT R237X/R237X 6/6
2 Saudi Arabia Yes 11901GrA/11901GrA Frameshift causing a stop, 1 codon downstream 10/10
3 France No 709CrT/8101GrA R237X/frameshift causing a stop, 20 codons
downstream
6/6
Figure 2 ADAMTS10 mutations and segregation of ﬂanking markers in the two consanguineous families
related matrix-associated actin-dependent regulator of
chromatin, subfamily A, member 4 (SMARCA4); the
tubulin b 5 gene (TUBB5); and ADAMTS10.
No deleterious mutations were identiﬁed by direct
sequencing of the COL5A3 gene. We then considered
ADAMTS10 as a candidate gene, since it belongs to a
family of proteases involved in the cleavage of procol-
lagen amino propeptide and aggrecan (Tang 2001; Cal
et al. 2002; Apte 2004). ADAMTS10 is composed of
24 coding exons and encodes a protein of 1,103 amino
acids that is composed of one disintegrin-like domain,
one metalloprotease domain, one cysteine-rich domain,
and ﬁve TS type 1 repeats. By direct sequencing, three
distinct mutations were identiﬁed, including one non-
sense mutation (R237X) and two splice-site mutations
(11901GrA and 8101GrA) (ﬁg. 1). The three mu-
tations predicted premature termination of translation
and were located in the predicted metalloprotease do-
main (table 1). The mutations and the ﬂanking poly-
morphic markers were found to cosegregate with the
disease (ﬁg. 2) and were not identiﬁed in 210 control
chromosomes.
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Figure 3 A, Northern analysis of the ADAMTS10 gene in various human fetal tissues. Note the presence of three distinct transcripts, of
5.5, 2.0, and 1.7 kb, probably corresponding to alternative splicing of the same RNA transcript. B, Human multiple-tissue expression array of
ADAMTS10. 1A–1H, 2A–2H, and 3B, Brain. 4A, Heart. 4B, Aorta. 4C, Atrium, left. 4D, Atrium, right. 4G, Intraventricular septum. 4H,
Apex of the heart. 5A–5H and 6A–6C, Digestive tract. 5B, Stomach. 7A, Kidney. 7B, Skeletal muscle. 8D–8G, Genitourinary tissues. 9A, Liver.
9B, Pancreas. 9E, Salivatory gland. 10A–10H, Leukemia and malignant cell lines. 11A, Fetal brain. 11B, Fetal heart. 11C, Fetal kidney. 11D,
Fetal liver. 11E, Fetal spleen. 11F, Fetal thymus. 11G, Fetal lung. C, RT-PCR detection of ADAMTS10 RNA in skin ﬁbroblasts from patient
2, control ﬁbroblasts, and control fetal chondrocytes. The speciﬁc transcript is detected in ﬁbroblasts and chondrocytes. Note the abnormal
size and weak signal of ADAMTS10 transcript in patient 2, corresponding to unstable mRNA.
Dot-blot analyses detected a speciﬁc signal in a large
number of tissues (except gonads, the majority of the
digestive tract, and malignant cells) but particularly in
adult heart, stomach, kidney, and skeletal muscle (ﬁg.
3B). Moreover, northern and dot-blot analyses of fetal
tissues showed a very weak signal in brain but a speciﬁc
signal in lung, liver, kidney (ﬁg. 3A and 3B), and heart
(ﬁg. 3B). RT-PCR analysis detected a speciﬁc signal in
skin ﬁbroblasts and fetal chondrocytes from controls
(ﬁg. 3C). By contrast, RT-PCR analysis of ﬁbroblast
RNA from affected individuals detected a weak signal
in all cases and an abnormally long transcript in the
two patients carrying splice-site mutations correspond-
ing to intron inclusion (patient 2, ﬁg. 3C)
The study of actin distribution (by use of Phalloidin-
Alexa) in cultured ﬁbroblasts of patients with WMS
showed large cytoplasmic extensions and a stronger
ﬂuorescent signal compared with controls (ﬁg. 3).More-
over, staining of WMS ﬁbroblasts revealed the presence
of thick and straight bundles of actin ﬁlaments aligned
in parallel and penetrating deeply within long cyto-
plasmic extensions. By contrast, actin ﬁlaments of con-
trols were less numerous, shorter, and located mainly
in the central part of the cells (ﬁg. 4).
Discussion
We report here three distinct nonsense and frameshift
mutations of the ADAMTS10 gene in three families with
the AR form of WMS. The mutations were located in
the catalytic domain of the protein and predicted the
generation of a markedly truncated protein.
ADAMTS is a family of proteins believed to be an-
chored to the ECM through interactions with aggregan
or other matrix components, via one or more TS type
1 motifs. This family of metalloproteases has structural
and functional properties related to (but distinct from)
the ADAMS family by the presence of several TS-like
domains in the C-terminal region and the lack of trans-
membrane domain. They are therefore secreted and
associated with the ECM, which is proteolytically pro-
cessed. At least 19 enzymes (1–20) have been char-
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Figure 4 Actin organization in the cultured ﬁbroblasts of patients and controls (Phalloidin-Alexa staining). Note the reduced intensity of
actin staining in control cells and the large actin bundles in a long cytoplasmic extension of patient ﬁbroblasts.
acterized to date (Tang 2001; Cal et al. 2002; Apte
2004). They all share the same genomic organization,
consisting of a signal sequence, a propeptide domain,
a metalloproteinase domain containing a zinc-binding
active-site motif (similar to that of the ADAMS pro-
teases), a disintegrin-like domain, a cysteine-rich re-
gion, and a variable number of TS-1 repeats. Overall,
the mammalian ADAMTS genes show 20%–40% sim-
ilarity to each other, with different recognizable sub-
families. ADAMTS10 differs from the others by the
presence of ﬁve TS domains and a unique C-terminal
PLAC (protease and lacunin) domain and is closely
related to ADAMTS6.
The ADAMTS protein family has previously been
shown to be involved in various human biological pro-
cesses (normal or pathological), including connective tissue
organization, coagulation, inﬂammation, arthritis, angi-
ogenesis, and cell migration. ADAMTS2, -3 (procollagen
N-propeptidase), and -14 process the amino peptide of
the procollagens I, II, and III, and ADAMTS2mutations
are known to cause autosomal recessive Ehlers-Danlos
syndrome type VIIC (Colige et al. 1999). ADAMTS4,
-5, and -11 are aggreganases involved in articular
cartilage aggregan degradation in arthritic disease
(Caterson et al. 2000; Sandy and Verscharen 2001).
ADAMTS4 also has the ability to process brevican in
the brain. Decreased ADAMTS13 (i.e., von Willebrand
factor–cleaving protease) activity is responsible for
thrombotic thrombocytopenic purpura (Kokame et al.
2002). Finally, ADAMTS1, -8 and, presumably, -15
have angio-inhibitory activities (Cal et al. 2002). The
other members of this family (ADAMTS6, -7, -9, -12,
and -16 through -19) and ADAMTS10 have been char-
acterized only at the structural level, and their putative
role and substrate remain unknown.
Since WMS is a connective tissue disorder character-
ized by microspherophakia, lens dislocation, progres-
sive joint stiffness, and short stature with brachydactyly,
it is important to note that the speciﬁc transcript was
detected not only in skin ﬁbroblasts but also in chon-
drocytes, which accounts for the short stature and
brachydactyly in WMS. ADAMTS10 was also ex-
pressed in fetal lung, liver, and kidney, as previously
shown for other ADAMTS gene products (Cal et al.
2002); however, at variance with the other gene products,
ADAMTS10 was expressed in fetal and adult heart, a
feature that is likely to be related to the cardiac defects
observed in WMS. The members of the ADAMTS family
have nonredundant functions in organogenesis, and the
speciﬁc pattern of expression in heart, chondrocytes, and
skin is probably a distinct characteristic of ADAMTS10.
Previous studies (using light microscopic examination
and electron micrographs) of skin ﬁbroblasts of a child
with WMS have shown normal diameter and striation
of collagen ﬁbrils but abnormal extraﬁbrillary space and
unusually large bundles of microﬁlaments within the
cells (Faivre et al. 2002). These ﬁndings were highly
suggestive of an impaired ECM. In fact, our immuno-
logical studies show the presence of abnormally large
bundles of actin ﬁlaments, which are a reﬂection of
cytoskeleton anomalies in WMS. The relationships be-
tween these cytoskeletal defects and ADAMST10 deﬁ-
ciencies remain unknown, but the abnormal actin dis-
tribution and organization in WMS ﬁbroblasts could be
the result of impaired connections between ECM com-
ponents and cytoskeleton. Moreover, the observation of
ﬁbrillin-1 mutation in AD WMS (which is clinically un-
distinguishable from AR WMS) suggests a close inter-
action between ADAMTS10 and ﬁbrillin 1. It is even
tempting to hypothesize that ﬁbrillin 1 could act a sub-
strate for ADAMTS10 in the ECM. The extensive iden-
tiﬁcation of ADAMTS10 ECM substrates would be
particularly valuable for further understanding these
complex interactions.
In conclusion, our study shows that null mutations
in ADAMTS10 are responsible for the AR form ofWMS
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with major impairment of the ECM. This study em-
phasizes the speciﬁc role of ADAMTS10 not only in
skin development but also in growth and in lens and
heart development. Additional studies will be important
to further deﬁne the speciﬁc function of ADAMTS10
in ECM remodeling during cell migration and invasion.
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